WeVote
Log In

Bill

Bill

SB 219

An Act relating to utilization review entities; exempting certain health care providers from making preauthorization requests for certain services; and providing for an effective date.

33rd Legislature (2023-2024) Introduced by David Wilson

Alaska bill exempts certain healthcare providers from requiring insurance preauthorization for specific services, accelerating care delivery but potentially increasing healthcare costs and reducing utilization review oversight.

(S) Minutes (SHSS)
#appeals #claims #contracts #health&socialservices #insurance #medicalcare #occupations&professions
0
WeVote Research Nonpartisan
Bill Summary · SB 219

Legislative bill overview

SB 219 would exempt certain healthcare providers in Alaska from the requirement to obtain preauthorization (prior approval) from insurance companies before delivering specific medical services. The bill targets utilization review entities and aims to streamline care delivery by reducing administrative delays for designated provider categories or service types.

Why is this important

Preauthorization requirements can delay patient care and increase administrative burden on providers, potentially affecting treatment timelines for urgent or time-sensitive conditions. Conversely, preauthorization exists to control costs and prevent unnecessary procedures. This bill represents a policy choice to prioritize faster access for certain providers or services over insurance company review gatekeeping.

Potential points of contention

  • Which providers/services are exempt: The bill's language doesn't specify which providers or services qualify for exemption, creating uncertainty about scope and potential for narrow vs. broad application
  • Cost implications: Removing preauthorization requirements could increase healthcare utilization and insurance claims costs, raising premiums or reducing coverage elsewhere
  • Insurance company oversight: Eliminates insurers' ability to identify potentially unnecessary procedures, creating quality control and fraud prevention concerns
  • Equity issues: Exempting certain providers could create disparities in approval speed based on provider type rather than medical necessity

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.